Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
US-10087239-B2 · Oct 2, 2018 · US
This page is not indexed by search engines while we improve data quality.
Theraclone Sciences Inc patents in 2018
Theraclone Sciences Inc was listed as an assignee on 3 patent publications in 2018.
| Metric | Value |
|---|---|
| Company | Theraclone Sciences Inc |
| Year | 2018 |
| Patents | 3 |
Patents
Representative publications for Theraclone Sciences Inc in 2018.
Top CPC classifications
Most common classification codes for Theraclone Sciences Inc in 2018.
| CPC | Patents |
|---|---|
| A61K2039/505 | 3 |
| A61K39/21 | 3 |
| C07K16/1063 | 3 |
| C07K16/114 | 3 |
| C07K16/1145 | 3 |
Related pages
Navigate to parent entity pages.